CTNM
Contineum Therapeutics, Inc. Class A Common Stock · Health Care · NASDAQ
$15.10
▼ $0.14 (−0.92%)
Market cap
$446.4M
52-week range
$3.69 – $16.33
Volume
196K
Previous close
$15.24
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Suvretta Capital.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Suvretta Capital Aaron Cowen |
0.9% | 2.8M | $37M | — | $15.17 | 2026-03-31 |
| HHLR Advisors Hillhouse |
0.5% | 669K | $9M | — | $17.61 | 2026-03-31 |
FAQ ▾
Which hedge funds hold CTNM?
Tracked holders include: Suvretta Capital, HHLR Advisors.
How much smart money owns CTNM?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading CTNM?
No tracked Congressional trades in CTNM on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.